Cause of death, by non-communicable diseases, male in Algeria
Algeria: Cause of death, by non-communicable diseases, male was 67.1% in 2021. ▬ Flat
Cause of death, by non-communicable diseases, male in Algeria, 2000–2021
Source: Global Health Estimates, World Health Organization (WHO). Measured in % of total male deaths.
Analysis
In 2021, cause of death, by non-communicable diseases, male in Algeria stood at 67.1%.
Compared with earlier readings it is up 25.5% on the previous year and down 5.1% over ten years.
Over the whole period, cause of death, by non-communicable diseases, male in Algeria peaked at 76.0% in 2019 and was at its lowest, 53.4%, in 2020.
Algeria ranks 69th of 185 countries on this measure, in the middle of the range.
Cause of death, by non-communicable diseases, male in Algeria, year by year
| Year | % of total male deaths | Change |
|---|---|---|
| 2000 | 65.1% | — |
| 2010 | 70.7% | +8.7% |
| 2015 | 72.9% | +3.1% |
| 2019 | 76.0% | +4.3% |
| 2020 | 53.4% | -29.7% |
| 2021 | 67.1% | +25.5% |
Algeria compared with similar countries
- Algeria's 67.1% is above the median for upper middle income countries, which is 59.4%, 1.1× the median. (55 countries reporting)
- Algeria's 67.1% is above the median for Middle East, North Africa, Afghanistan & Pakistan, which is 58.1%, 1.2× the median. (23 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 65.1% | 65.1% | 65.1% | 1 |
| 2010s | 73.2% | 70.7% | 76.0% | 3 |
| 2020s | 60.2% | 53.4% | 67.1% | 2 |
Countries ranked near Algeria
- 66 Serbia 67.8% compare
- 67 Syria 67.2% compare
- 68 Philippines 67.2% compare
- 70 United Arab Emirates 66.9% compare
- 71 Solomon Islands 66.7% compare
- 72 North Macedonia 66.1% compare
More health data for Algeria
- Un projection of annual infant deaths, annual growth rate -1.82 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.5437 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 943.1 deaths per 1,000 people (2090)
- Number of infants who die before age 1 1,455 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate -2.77 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0465 units per person (2025)
- Population ages 00-04, male, annual growth rate -2.77 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is cause of death, by non-communicable diseases, male in Algeria?
- Cause of death, by non-communicable diseases, male in Algeria was 67.1% in 2021, according to Global Health Estimates, World Health Organization (WHO).
- What is the highest cause of death, by non-communicable diseases, male recorded in Algeria?
- The highest recorded value was 76.0% in 2019.
- What is the lowest cause of death, by non-communicable diseases, male recorded in Algeria?
- The lowest recorded value was 53.4% in 2020.
- How does Algeria rank for cause of death, by non-communicable diseases, male?
- Algeria ranks 69th out of 185 countries with data for 2021.
- Is cause of death, by non-communicable diseases, male rising or falling in Algeria?
- Over the last ten years it is down 5.1%. The long-run trend across the full record is flat.
- Where does this Algeria data come from?
- The figures come from Global Health Estimates, World Health Organization (WHO), published as part of Cause of death, by non-communicable diseases, male (% of total male deaths). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 6 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Number of male deaths ages due to non-communicable diseases divided by number of all male deaths ages, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.